Joint Formulary & PAD

Lidocaine - Complex pain management

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Medicated plaster
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Restricted to specialist pain or palliative care teams.  See PAD for information requirements on transfer to primary care

Documentation

PAD Profile

ChemicalSubstance :
Lidocaine
Indication :
Complex pain management
Group Name :
Keywords :
lidocaine patch, lidocaine plasters, palliative care, specialist pain management
Brand Names Include :
Versatis
Important Information :
Latest Additions Date From :
02 Apr 2025
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Lidocaine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Complex pain management.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the use of lidocaine plasters as BLUE (on initiation) following specialist pain team or palliative care team review and where a clinical need has been identified.

The specialist will be required to supply a 1 month minimum supply prior to transfer of care 

The specialist will be required to ensure the patient has responded to treatment and is stable before transferring care. They will be asked to provide the following information to the primary care prescriber in the clinic letter when transferring care.

o   Indication for initiation

o   MDT discussion/plan

o   Dose to be prescribed

o   Confirmation of response to initial treatment

o   Intended duration of treatment

o   Ongoing monitoring/assessment of response